Barclays analyst Benjamin Budish raised the firm’s price target on CME Group (CME) to $312 from $304 and keeps an Equal Weight rating on the shares post the Q4 report. The company reported an earnings beat and its fiscal 2026 guidance was in line with consensus, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group reports Q4 adjusted EPS $2.77, consensus $2.74
- These Are the Stocks Reporting Earnings Today – February 4, 2026
- CME Group reports January average daily volume 29.6M contracts
- Plus500 Stock Pops 8% on Launch of CFTC-Regulated Prediction Markets Platform for U.S. Traders
- Why Trump’s Choice for Fed Chair, Kevin Warsh, Is Seen as a Double-Edged Sword for Crypto